Gschwandtner, Martha <br/><br/>
Glycosaminoglycan silencing by engineered CXCL12 variants.  [electronic resource] 

 -  FEBS letters  Sep 2015 
 - 2819-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-3468 
<br/><br/><label>Standard No.: </label>10.1016/j.febslet.2015.07.052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Chemokine CXCL12--genetics<br/>Female<br/>Gene Silencing<br/>Glycosaminoglycans--deficiency<br/>Humans<br/>Liver--pathology<br/>Mice<br/>Mutation<br/>Protein Engineering<br/>Receptors, G-Protein-Coupled--metabolism<br/>Signal Transduction--genetics